Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Speech Perception | 88 | 2022 | 261 | 18.390 |
Why?
|
Hearing Loss | 40 | 2022 | 154 | 13.830 |
Why?
|
Noise | 52 | 2022 | 153 | 8.410 |
Why?
|
Perceptual Masking | 39 | 2022 | 78 | 7.280 |
Why?
|
Auditory Threshold | 70 | 2022 | 206 | 6.800 |
Why?
|
Hearing | 44 | 2022 | 133 | 6.640 |
Why?
|
Cochlear Implants | 19 | 2022 | 110 | 6.240 |
Why?
|
Hearing Loss, Sensorineural | 37 | 2022 | 110 | 6.070 |
Why?
|
Cochlear Implantation | 17 | 2022 | 99 | 6.030 |
Why?
|
Aging | 40 | 2020 | 911 | 5.760 |
Why?
|
Presbycusis | 18 | 2022 | 84 | 5.560 |
Why?
|
Hearing Aids | 15 | 2022 | 34 | 4.100 |
Why?
|
Auditory Perception | 22 | 2022 | 89 | 4.050 |
Why?
|
Acoustic Stimulation | 42 | 2022 | 206 | 3.660 |
Why?
|
Hearing Tests | 18 | 2022 | 70 | 3.570 |
Why?
|
Persons With Hearing Impairments | 8 | 2020 | 22 | 3.150 |
Why?
|
Aged | 116 | 2022 | 14862 | 2.960 |
Why?
|
Deafness | 10 | 2022 | 64 | 2.870 |
Why?
|
Quality of Life | 17 | 2022 | 1515 | 2.790 |
Why?
|
Auditory Cortex | 9 | 2017 | 43 | 2.560 |
Why?
|
Aged, 80 and over | 51 | 2021 | 4848 | 2.410 |
Why?
|
Speech Acoustics | 10 | 2018 | 23 | 2.350 |
Why?
|
Audiometry, Pure-Tone | 34 | 2020 | 96 | 2.350 |
Why?
|
Patient Reported Outcome Measures | 6 | 2020 | 114 | 2.250 |
Why?
|
Phonetics | 17 | 2020 | 42 | 2.110 |
Why?
|
Cues | 13 | 2021 | 654 | 2.060 |
Why?
|
Adult | 104 | 2022 | 21403 | 2.060 |
Why?
|
Humans | 180 | 2022 | 68618 | 2.050 |
Why?
|
Speech | 13 | 2022 | 118 | 2.000 |
Why?
|
Middle Aged | 99 | 2022 | 21147 | 1.960 |
Why?
|
Age Factors | 30 | 2021 | 1864 | 1.930 |
Why?
|
Cochlear Nerve | 10 | 2022 | 83 | 1.820 |
Why?
|
Attention | 14 | 2020 | 225 | 1.650 |
Why?
|
Male | 97 | 2022 | 37321 | 1.550 |
Why?
|
Female | 97 | 2022 | 38074 | 1.530 |
Why?
|
Audiometry | 9 | 2021 | 50 | 1.490 |
Why?
|
Hearing Disorders | 5 | 2017 | 23 | 1.470 |
Why?
|
Young Adult | 38 | 2020 | 5717 | 1.470 |
Why?
|
Basilar Membrane | 4 | 2012 | 16 | 1.400 |
Why?
|
Otoacoustic Emissions, Spontaneous | 3 | 2020 | 19 | 1.390 |
Why?
|
Psychoacoustics | 13 | 2015 | 33 | 1.360 |
Why?
|
Evoked Potentials, Auditory | 6 | 2018 | 47 | 1.290 |
Why?
|
Diagnostic Self Evaluation | 2 | 2019 | 18 | 1.250 |
Why?
|
Voice Quality | 3 | 2018 | 21 | 1.240 |
Why?
|
Ossicular Prosthesis | 2 | 2018 | 10 | 1.180 |
Why?
|
Auditory Pathways | 3 | 2017 | 20 | 1.180 |
Why?
|
Speech Intelligibility | 5 | 2017 | 14 | 1.160 |
Why?
|
Cochlea | 9 | 2020 | 169 | 1.120 |
Why?
|
Audiology | 4 | 2018 | 8 | 1.050 |
Why?
|
Health Expenditures | 2 | 2018 | 170 | 0.990 |
Why?
|
Hearing Loss, High-Frequency | 6 | 2021 | 16 | 0.980 |
Why?
|
Pitch Perception | 4 | 2013 | 14 | 0.910 |
Why?
|
Longitudinal Studies | 11 | 2022 | 1054 | 0.900 |
Why?
|
Psychometrics | 13 | 2021 | 514 | 0.870 |
Why?
|
Motivation | 3 | 2022 | 561 | 0.820 |
Why?
|
Action Potentials | 4 | 2022 | 223 | 0.820 |
Why?
|
Sound Localization | 3 | 2014 | 7 | 0.760 |
Why?
|
Speech Reception Threshold Test | 7 | 2019 | 25 | 0.750 |
Why?
|
Cognition | 6 | 2021 | 513 | 0.740 |
Why?
|
Loudness Perception | 5 | 2010 | 13 | 0.720 |
Why?
|
Correction of Hearing Impairment | 3 | 2017 | 4 | 0.700 |
Why?
|
Signal Detection, Psychological | 4 | 2013 | 21 | 0.680 |
Why?
|
Prospective Studies | 10 | 2022 | 3705 | 0.680 |
Why?
|
Time-to-Treatment | 2 | 2020 | 117 | 0.660 |
Why?
|
Treatment Outcome | 10 | 2022 | 7029 | 0.660 |
Why?
|
Cross-Sectional Studies | 10 | 2022 | 2279 | 0.650 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 306 | 0.650 |
Why?
|
Ear, Middle | 2 | 2018 | 32 | 0.640 |
Why?
|
Signal-To-Noise Ratio | 8 | 2022 | 93 | 0.620 |
Why?
|
Audiometry, Speech | 7 | 2018 | 14 | 0.610 |
Why?
|
Adolescent | 23 | 2019 | 8912 | 0.610 |
Why?
|
Data Interpretation, Statistical | 1 | 2019 | 329 | 0.600 |
Why?
|
Models, Neurological | 4 | 2017 | 136 | 0.600 |
Why?
|
Brain | 3 | 2019 | 2176 | 0.580 |
Why?
|
Time Factors | 14 | 2019 | 4655 | 0.570 |
Why?
|
Insurance, Health | 1 | 2018 | 201 | 0.560 |
Why?
|
Medicare | 1 | 2018 | 319 | 0.530 |
Why?
|
Health Services | 1 | 2016 | 87 | 0.510 |
Why?
|
Neural Pathways | 3 | 2014 | 324 | 0.510 |
Why?
|
Health Care Costs | 1 | 2018 | 346 | 0.500 |
Why?
|
Olfaction Disorders | 3 | 2022 | 100 | 0.500 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 7 | 2014 | 49 | 0.490 |
Why?
|
Patient Selection | 1 | 2018 | 592 | 0.480 |
Why?
|
Hearing Loss, Noise-Induced | 3 | 2013 | 46 | 0.470 |
Why?
|
Evoked Potentials | 1 | 2014 | 61 | 0.470 |
Why?
|
Needs Assessment | 1 | 2015 | 186 | 0.460 |
Why?
|
Hair Cells, Auditory, Outer | 3 | 2022 | 33 | 0.450 |
Why?
|
Acoustics | 3 | 2021 | 20 | 0.450 |
Why?
|
Time Perception | 2 | 2011 | 9 | 0.440 |
Why?
|
Pattern Recognition, Physiological | 5 | 2017 | 22 | 0.440 |
Why?
|
Therapy, Computer-Assisted | 1 | 2013 | 57 | 0.440 |
Why?
|
Electroencephalography | 7 | 2021 | 418 | 0.440 |
Why?
|
Cerebral Small Vessel Diseases | 1 | 2013 | 10 | 0.440 |
Why?
|
Reaction Time | 8 | 2017 | 170 | 0.440 |
Why?
|
Magnetic Resonance Imaging | 14 | 2021 | 2223 | 0.430 |
Why?
|
Gyrus Cinguli | 5 | 2013 | 113 | 0.420 |
Why?
|
Auditory Perceptual Disorders | 1 | 2012 | 4 | 0.420 |
Why?
|
Analysis of Variance | 8 | 2016 | 1040 | 0.410 |
Why?
|
Frontal Lobe | 5 | 2019 | 156 | 0.410 |
Why?
|
Circadian Rhythm | 1 | 2013 | 218 | 0.410 |
Why?
|
C-Reactive Protein | 1 | 2013 | 180 | 0.400 |
Why?
|
Speech Discrimination Tests | 10 | 2008 | 17 | 0.400 |
Why?
|
Models, Biological | 3 | 2014 | 981 | 0.400 |
Why?
|
Artificial Intelligence | 1 | 2013 | 159 | 0.390 |
Why?
|
Surveys and Questionnaires | 6 | 2021 | 2800 | 0.380 |
Why?
|
Lipids | 1 | 2013 | 298 | 0.380 |
Why?
|
Reproducibility of Results | 8 | 2021 | 2077 | 0.370 |
Why?
|
Case-Control Studies | 6 | 2019 | 1553 | 0.350 |
Why?
|
Functional Laterality | 2 | 2009 | 240 | 0.340 |
Why?
|
Pitch Discrimination | 5 | 2008 | 11 | 0.340 |
Why?
|
Gerbillinae | 5 | 2022 | 156 | 0.340 |
Why?
|
Sound Spectrography | 6 | 2015 | 14 | 0.330 |
Why?
|
Parietal Lobe | 1 | 2009 | 59 | 0.330 |
Why?
|
Comprehension | 3 | 2018 | 71 | 0.330 |
Why?
|
Disease Models, Animal | 3 | 2014 | 2550 | 0.330 |
Why?
|
Retrospective Studies | 9 | 2022 | 7277 | 0.330 |
Why?
|
Ethmoid Bone | 2 | 2019 | 18 | 0.320 |
Why?
|
Temporal Lobe | 1 | 2009 | 125 | 0.320 |
Why?
|
Nasal Cavity | 2 | 2019 | 62 | 0.310 |
Why?
|
Hair Cells, Auditory | 3 | 2020 | 60 | 0.300 |
Why?
|
Discriminant Analysis | 2 | 2018 | 36 | 0.290 |
Why?
|
Smell | 4 | 2022 | 131 | 0.290 |
Why?
|
Brain Mapping | 6 | 2019 | 532 | 0.280 |
Why?
|
Nonlinear Dynamics | 4 | 2015 | 55 | 0.270 |
Why?
|
Communication | 3 | 2018 | 329 | 0.270 |
Why?
|
Reference Values | 8 | 2014 | 579 | 0.260 |
Why?
|
Hair Cells, Auditory, Inner | 2 | 2018 | 19 | 0.250 |
Why?
|
Nerve Fibers | 2 | 2022 | 77 | 0.250 |
Why?
|
Self Report | 3 | 2022 | 371 | 0.250 |
Why?
|
Phenotype | 3 | 2022 | 947 | 0.240 |
Why?
|
Language | 2 | 2022 | 120 | 0.230 |
Why?
|
Linear Models | 3 | 2019 | 521 | 0.220 |
Why?
|
Animals | 12 | 2022 | 20881 | 0.220 |
Why?
|
Cohort Studies | 2 | 2019 | 2358 | 0.210 |
Why?
|
Cerebral Cortex | 2 | 2016 | 415 | 0.200 |
Why?
|
Factor Analysis, Statistical | 2 | 2019 | 201 | 0.200 |
Why?
|
Semantics | 1 | 2022 | 37 | 0.200 |
Why?
|
Psychomotor Performance | 3 | 2019 | 213 | 0.200 |
Why?
|
Brain Stem | 3 | 2003 | 46 | 0.200 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 240 | 0.190 |
Why?
|
Patient Satisfaction | 2 | 2017 | 378 | 0.190 |
Why?
|
Postoperative Period | 2 | 2021 | 238 | 0.180 |
Why?
|
Loneliness | 1 | 2020 | 20 | 0.180 |
Why?
|
Regression Analysis | 2 | 2017 | 737 | 0.180 |
Why?
|
Cisplatin | 1 | 2021 | 192 | 0.170 |
Why?
|
Heart Diseases | 1 | 2022 | 276 | 0.170 |
Why?
|
Sex Factors | 6 | 2013 | 1266 | 0.170 |
Why?
|
Reflex, Acoustic | 2 | 2017 | 7 | 0.160 |
Why?
|
Periodicity | 1 | 2019 | 43 | 0.160 |
Why?
|
Olfactory Mucosa | 1 | 2018 | 11 | 0.160 |
Why?
|
Cross-Over Studies | 1 | 2019 | 260 | 0.160 |
Why?
|
Boston | 1 | 2018 | 35 | 0.150 |
Why?
|
Propensity Score | 1 | 2018 | 117 | 0.150 |
Why?
|
Mass Screening | 2 | 2022 | 843 | 0.150 |
Why?
|
Referral and Consultation | 1 | 2020 | 383 | 0.150 |
Why?
|
Computer Simulation | 3 | 2014 | 706 | 0.150 |
Why?
|
Wisconsin Card Sorting Test | 1 | 2017 | 3 | 0.150 |
Why?
|
Genetic Variation | 1 | 2018 | 220 | 0.150 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 1465 | 0.140 |
Why?
|
Neuropsychological Tests | 2 | 2009 | 517 | 0.140 |
Why?
|
United States | 4 | 2018 | 7367 | 0.140 |
Why?
|
Nerve Net | 2 | 2013 | 181 | 0.140 |
Why?
|
Focus Groups | 1 | 2017 | 247 | 0.140 |
Why?
|
Health Services Needs and Demand | 2 | 2015 | 149 | 0.140 |
Why?
|
Pupil | 2 | 2014 | 51 | 0.140 |
Why?
|
Executive Function | 1 | 2017 | 106 | 0.140 |
Why?
|
Primary Health Care | 2 | 2020 | 703 | 0.130 |
Why?
|
Prefrontal Cortex | 3 | 2017 | 640 | 0.130 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 955 | 0.130 |
Why?
|
Prevalence | 2 | 2020 | 1619 | 0.130 |
Why?
|
Tinnitus | 1 | 2015 | 22 | 0.130 |
Why?
|
Research Support as Topic | 1 | 2015 | 58 | 0.130 |
Why?
|
Delivery of Health Care | 2 | 2018 | 445 | 0.130 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 373 | 0.130 |
Why?
|
Health Behavior | 1 | 2019 | 458 | 0.130 |
Why?
|
Head and Neck Neoplasms | 1 | 2021 | 561 | 0.130 |
Why?
|
Emotions | 1 | 2017 | 244 | 0.130 |
Why?
|
Research Design | 1 | 2019 | 729 | 0.120 |
Why?
|
Congresses as Topic | 1 | 2015 | 85 | 0.120 |
Why?
|
Disability Evaluation | 1 | 2017 | 298 | 0.120 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2015 | 100 | 0.120 |
Why?
|
Risk Factors | 2 | 2016 | 5731 | 0.120 |
Why?
|
SOXE Transcription Factors | 1 | 2014 | 9 | 0.120 |
Why?
|
Heptanol | 1 | 2014 | 2 | 0.120 |
Why?
|
Round Window, Ear | 1 | 2014 | 8 | 0.120 |
Why?
|
Hearing Loss, Conductive | 1 | 2014 | 12 | 0.120 |
Why?
|
Task Performance and Analysis | 2 | 2016 | 150 | 0.110 |
Why?
|
Visual Perception | 2 | 2017 | 124 | 0.110 |
Why?
|
Cost-Benefit Analysis | 3 | 2022 | 504 | 0.110 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2013 | 109 | 0.110 |
Why?
|
Hearing Loss, Central | 1 | 2012 | 9 | 0.110 |
Why?
|
Vestibulocochlear Nerve Diseases | 1 | 2012 | 10 | 0.110 |
Why?
|
Quality-Adjusted Life Years | 2 | 2022 | 106 | 0.100 |
Why?
|
Biomedical Research | 1 | 2015 | 310 | 0.100 |
Why?
|
Hearing Loss, Bilateral | 2 | 2022 | 13 | 0.100 |
Why?
|
Myelin Basic Protein | 1 | 2012 | 62 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2018 | 689 | 0.100 |
Why?
|
Sound | 1 | 2011 | 16 | 0.100 |
Why?
|
Vocabulary | 1 | 2011 | 14 | 0.100 |
Why?
|
Language Tests | 1 | 2011 | 36 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 2324 | 0.100 |
Why?
|
Risk Assessment | 1 | 2018 | 2007 | 0.100 |
Why?
|
Adaptation, Physiological | 2 | 2010 | 189 | 0.100 |
Why?
|
Severity of Illness Index | 3 | 2016 | 1851 | 0.090 |
Why?
|
South Carolina | 1 | 2018 | 2752 | 0.090 |
Why?
|
Visual Cortex | 1 | 2011 | 67 | 0.090 |
Why?
|
Maternal Behavior | 2 | 2002 | 29 | 0.090 |
Why?
|
Databases, Factual | 1 | 2013 | 622 | 0.090 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 438 | 0.090 |
Why?
|
Space Perception | 1 | 2009 | 44 | 0.080 |
Why?
|
Vestibulocochlear Nerve | 1 | 1989 | 17 | 0.080 |
Why?
|
Mice, Inbred CBA | 3 | 2014 | 107 | 0.080 |
Why?
|
Histamine H1 Antagonists | 2 | 1999 | 22 | 0.080 |
Why?
|
Adrenergic beta-Agonists | 2 | 1999 | 92 | 0.080 |
Why?
|
Workload | 1 | 2009 | 103 | 0.080 |
Why?
|
Calcium Channel Blockers | 2 | 1999 | 138 | 0.080 |
Why?
|
Oxygen | 3 | 2017 | 386 | 0.080 |
Why?
|
Normal Distribution | 1 | 2008 | 46 | 0.080 |
Why?
|
Psychophysics | 5 | 2000 | 30 | 0.070 |
Why?
|
Infant, Newborn | 4 | 2002 | 2455 | 0.070 |
Why?
|
Biomarkers | 1 | 2013 | 1593 | 0.070 |
Why?
|
Progesterone | 1 | 2008 | 115 | 0.070 |
Why?
|
Child Development | 1 | 1987 | 102 | 0.070 |
Why?
|
Neural Inhibition | 1 | 2007 | 80 | 0.070 |
Why?
|
Acoustic Impedance Tests | 2 | 2013 | 11 | 0.070 |
Why?
|
Dichotic Listening Tests | 1 | 2005 | 2 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2010 | 581 | 0.060 |
Why?
|
Algorithms | 1 | 2010 | 1196 | 0.060 |
Why?
|
Organ Size | 2 | 2018 | 242 | 0.060 |
Why?
|
Biology | 1 | 2022 | 14 | 0.050 |
Why?
|
Uncertainty | 1 | 2022 | 31 | 0.050 |
Why?
|
Linguistics | 1 | 2022 | 10 | 0.050 |
Why?
|
Thalamic Nuclei | 1 | 2002 | 9 | 0.050 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 38 | 0.050 |
Why?
|
United Kingdom | 1 | 2022 | 152 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2022 | 219 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2008 | 3259 | 0.050 |
Why?
|
Nutrition Surveys | 1 | 2022 | 208 | 0.050 |
Why?
|
Mice | 3 | 2022 | 8474 | 0.050 |
Why?
|
Independent Living | 1 | 2020 | 44 | 0.040 |
Why?
|
Biometry | 1 | 2020 | 72 | 0.040 |
Why?
|
Sensory Thresholds | 1 | 2019 | 50 | 0.040 |
Why?
|
Physical Stimulation | 1 | 1999 | 67 | 0.040 |
Why?
|
Clinical Decision-Making | 1 | 2020 | 109 | 0.040 |
Why?
|
Crying | 1 | 1999 | 6 | 0.040 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1999 | 189 | 0.040 |
Why?
|
Bone Conduction | 1 | 1978 | 9 | 0.040 |
Why?
|
Reflex | 1 | 1978 | 21 | 0.040 |
Why?
|
Age of Onset | 1 | 2018 | 188 | 0.040 |
Why?
|
Temporal Bone | 2 | 2014 | 53 | 0.040 |
Why?
|
Dissection | 1 | 2018 | 29 | 0.040 |
Why?
|
Cadaver | 1 | 2018 | 136 | 0.040 |
Why?
|
Skull Base | 1 | 2018 | 72 | 0.040 |
Why?
|
Bone Density | 1 | 2018 | 159 | 0.040 |
Why?
|
Memory, Short-Term | 1 | 2017 | 79 | 0.040 |
Why?
|
Models, Theoretical | 2 | 1997 | 384 | 0.040 |
Why?
|
Photic Stimulation | 1 | 2017 | 229 | 0.030 |
Why?
|
Incidence | 1 | 2021 | 1603 | 0.030 |
Why?
|
Electric Stimulation | 1 | 2017 | 218 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 261 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 93 | 0.030 |
Why?
|
Individuality | 1 | 2015 | 44 | 0.030 |
Why?
|
Carbonic Anhydrase III | 1 | 2014 | 3 | 0.030 |
Why?
|
Spiral Ligament of Cochlea | 1 | 2014 | 3 | 0.030 |
Why?
|
Stria Vascularis | 1 | 2014 | 31 | 0.030 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 72 | 0.030 |
Why?
|
Evaluation Studies as Topic | 3 | 1982 | 219 | 0.030 |
Why?
|
Diffusion Tensor Imaging | 1 | 2015 | 211 | 0.030 |
Why?
|
Mutation | 1 | 2018 | 1213 | 0.030 |
Why?
|
Random Allocation | 1 | 2014 | 442 | 0.030 |
Why?
|
Tissue Donors | 1 | 2014 | 195 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2012 | 196 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2012 | 127 | 0.030 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2010 | 11 | 0.020 |
Why?
|
National Institute on Deafness and Other Communication Disorders (U.S.) | 1 | 2010 | 1 | 0.020 |
Why?
|
Forecasting | 1 | 2011 | 277 | 0.020 |
Why?
|
Financing, Government | 1 | 2010 | 16 | 0.020 |
Why?
|
Furosemide | 1 | 2010 | 45 | 0.020 |
Why?
|
Financing, Personal | 1 | 2010 | 17 | 0.020 |
Why?
|
Health Care Reform | 1 | 2010 | 62 | 0.020 |
Why?
|
Research | 1 | 2010 | 214 | 0.020 |
Why?
|
Infant | 2 | 2002 | 2891 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2010 | 378 | 0.020 |
Why?
|
Health Promotion | 1 | 2010 | 407 | 0.020 |
Why?
|
Preoptic Area | 1 | 2002 | 19 | 0.010 |
Why?
|
Voice | 1 | 1982 | 16 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2002 | 65 | 0.010 |
Why?
|
Arousal | 1 | 2002 | 168 | 0.010 |
Why?
|
Object Attachment | 1 | 1999 | 20 | 0.010 |
Why?
|
Models, Psychological | 1 | 2000 | 180 | 0.010 |
Why?
|
Mother-Child Relations | 1 | 1999 | 43 | 0.010 |
Why?
|
Blood Viscosity | 1 | 1998 | 9 | 0.010 |
Why?
|
Blood Chemical Analysis | 1 | 1998 | 43 | 0.010 |
Why?
|
Health Surveys | 1 | 1999 | 489 | 0.010 |
Why?
|
Sex Distribution | 1 | 1998 | 274 | 0.010 |
Why?
|
Feasibility Studies | 1 | 1999 | 652 | 0.010 |
Why?
|
Child | 1 | 1987 | 6405 | 0.010 |
Why?
|
Pilot Projects | 1 | 1999 | 1342 | 0.010 |
Why?
|
Microcomputers | 1 | 1981 | 32 | 0.000 |
Why?
|
Amplifiers, Electronic | 1 | 1981 | 4 | 0.000 |
Why?
|